Latest Hematological malignancy Stories
SEATTLE, April 22, 2015 /PRNewswire/ -- Adaptive Biotechnologies today announced the recent publication of a study demonstrating that analysis of circulating tumor DNA (ctDNA) using the company's
Oral Presentation at the American Association of Cancer Research Annual Meeting PHILADELPHIA, April 20, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
Esten and leukemia survivor daughter Addie to join thousands across the country for Light The Night Walks to raise funds for cancer cures WHITE PLAINS, N.Y., April 13, 2015 /PRNewswire/
Influential Leaders Compete to Raise Funds in Honor of Local Blood Cancer Survivors SANTA ROSA, Calif., April 8, 2015 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's
SOUTH SAN FRANCISCO, Calif., April 6, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc.
WHITE PLAINS, N.Y., March 30, 2015 /PRNewswire-USNewswire/ -- A promising University of Michigan research project focused on developing new treatments for patients with a rare and lethal subtype
BEVERLY HILLS, Calif., March 24, 2015 /PRNewswire/ -- Rich Pharmaceuticals, Inc.
LLS Mobilizes Influential Leaders across the Bay Area in the Fight against Blood Cancers SAN FRANCISCO, March 17, 2015 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's
Independent Data Monitoring Committee determines HELIOS study meets its primary endpoint of progression-free survival in patients with previously treated chronic lymphocytic leukemia/small lymphocytic
BEVERLY HILLS, Calif., Feb. 23, 2015 /PRNewswire/ -- Rich Pharmaceuticals, Inc.
- A person in a secondary role, specifically the second most important character (after the protagonist).